GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Numinus Wellness Inc (FRA:LR23) » Definitions » EPS (Diluted)

Numinus Wellness (FRA:LR23) EPS (Diluted) : €-0.07 (TTM As of Feb. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Numinus Wellness EPS (Diluted)?

Numinus Wellness's Earnings per Share (Diluted) for the three months ended in Feb. 2024 was €-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was €-0.07.

Numinus Wellness's EPS (Basic) for the three months ended in Feb. 2024 was €-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 was €-0.07.

Numinus Wellness's EPS without NRI for the three months ended in Feb. 2024 was €-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 was €-0.06.

During the past 3 years, the average EPS without NRIGrowth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Numinus Wellness's highest 3-Year average EPS without NRI Growth Rate was 3.90% per year. The lowest was -14.90% per year. And the median was -5.50% per year.


Numinus Wellness EPS (Diluted) Historical Data

The historical data trend for Numinus Wellness's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Numinus Wellness EPS (Diluted) Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23
EPS (Diluted)
-0.07 -0.10 -0.07 -0.16 -0.08

Numinus Wellness Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.02 -0.01 -0.01

Competitive Comparison of Numinus Wellness's EPS (Diluted)

For the Medical Care Facilities subindustry, Numinus Wellness's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Numinus Wellness's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's PE Ratio distribution charts can be found below:

* The bar in red indicates where Numinus Wellness's PE Ratio falls into.



Numinus Wellness EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Numinus Wellness's Diluted EPS for the fiscal year that ended in Aug. 2023 is calculated as

Diluted EPS (A: Aug. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-20.585-0)/263.632
=-0.08

Numinus Wellness's Diluted EPS for the quarter that ended in Feb. 2024 is calculated as

Diluted EPS (Q: Feb. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-4.088-0)/263.655
=-0.02

EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Numinus Wellness  (FRA:LR23) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Numinus Wellness EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Numinus Wellness's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Numinus Wellness (FRA:LR23) Business Description

Traded in Other Exchanges
Address
801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.

Numinus Wellness (FRA:LR23) Headlines

No Headlines